QualityMetric’s SF-36v2 PRO Survey Contributes to EU’s ORCHESTRA SARS-CoV2 Impact Research

New York, September 14, 2021 — QualityMetric (QM), a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO), has announced its collaboration  in ORCHESTRA, a three-year international research project led by the University of Verona to measure the impact of the SARS-CoV2 pandemic. The project involves thirty-seven total partners […]


Understanding Rare Cancers Using Patient-Reported Outcome Measures

Many fields in healthcare research benefit from leveraging clinician outcome assessments (COAs) to gain a deeper understanding of patient experiences. Patient-reported outcome (PRO) measures, or PROM, have seen an increased use over the years in clinical trials and other treatment delivery settings. These measurements paint a more complete picture of the spectrum of symptoms and […]

Read More

Understanding the Functions & Benefits of a Health Utility Survey & Index

Health providers require flexible tools for calculating health-related quality of life (HRQoL) with precision—and life sciences companies need innovative tools to prove value in the product lifecycle. Instruments for accomplishing both goals aren’t always widely applicable, convenient, straightforward or fully responsive to the health changes patients experience. This is why organizations across the healthcare continuum […]

Read More

Score Range for the SF-36v2 Health Survey – Standard and Acute Versions

This FAQ response describes the score range for the SF-36v2® Health Survey Standard and Acute Versions when scored according to norms from QualityMetric’s 2009 norm study.   In the original scoring of the SF-36, the eight subscales (PF, RP, BP, GH, VT, SF, RE, MH) were scored from 0 (worst health) to 100 (best heath). […]

Read More

The Increasing Importance of Linguistic Validation in the Healthcare Product Lifecycle

Rigorous and technical translation processes guide the development of content for a variety of products across the healthcare ecosystem. Patients, caregivers, clinicians, study site leaders and other key stakeholders rely on accurate information for research or care delivery in the pharmaceutical, biotechnology and medical device markets. Marketing finished endpoints, such as new drugs, therapies, treatment […]

Read More

QualityMetric and Survivor Healthcare enter a partnership to study unmet cognitive health needs of cancer patients.

Rhode Island — September 30, 2021 —QualityMetric, today announced a new partnership with Survivor Healthcare. The companies will be partnering to implement and measure an integrated program designed to improve cognitive functioning and overall health quality of life for cancer patients.

Read More

An In-Depth Guide to Patient-Reported Outcome Measures | QualityMetric

Clinician-reported outcome (ClinRO) measures are the gold standard for assessing patient experiences in clinical research. Over the years, routine care and clinical research have benefitted from incorporating data derived directly from real patient experiences through patient-reported outcome (PRO) measures, also known as PROMs. PRO instruments are increasingly valued in clinical trial settings and treatment delivery, […]

Read More

Pulse Infoframe and QualityMetric Partner to Develop Novel Rare Disease Solution

QualityMetric and Pulse Infoframe announced today their partnership and vision to create the first scientifically validated rare disease instruments across conditions. Once deployed, these instruments will benefit not only rare disease patients and families, but also researchers and drug developers working to help this vastly underserviced population as they advance rare disease care and treatments.

Read More

Vesey Street Capital Partners-Backed QualityMetric Adds Angela Host as Chief Commercial Officer

Ms. Host’s distinguished career spans 20+ years, with progressively larger leadership roles in healthcare across life sciences, provider, and payer markets.

Read More

Vesey Street Capital Partners-Backed QualityMetric Adds John Hart as Chief Financial Officer

Mr. Hart will join the team led by Chief Executive Officer Garth “Gus” Gardner, who has been in that role since soon after the VSCP-led recapitalization of the company in August of 2020.

Read More

QualityMetric Co-authors New Qualitative Study on hATTR

QualityMetric’s own Kimberly Raymond, Andrew Lovley, and Michelle White co-author a new study on the humanistic burden of hereditary transthyretin (hATTR) amyloidosis from the patient’s perspective.

Read More